#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma recurrent Vulval cancer recurrent Candida infection Cutaneous T-cell lymphoma refractory Sickle cell anaemia Hereditary angioedema with C1 esterase inhibitor deficiency Glomerulonephritis rapidly progressive Immune-mediated enterocolitis Depression Glomerulonephritis minimal lesion Neoplasm Angiosarcoma recurrent Insulinoma Gastrointestinal stromal tumour Osteopetrosis More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Diagnostics Bronchopulmonary dysplasia Paroxysmal nocturnal haemoglobinuria – Trials in Disease Mucopolysaccharidosis III VEXAS syndrome – Life with Disease Biotinidase deficiency – Life with Disease Anaplastic thyroid cancer – Treatment Factor IX deficiency Wolfram syndrome – Diagnostics Gaucher’s disease type III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Botulinum Toxin Type A Img-007 A/H1N1 INFLUENZA VACCINE Sodium Hypochlorite Sodium Thiosulfate L-Histidine Hydrochloride Keto-Leucine Calcium Clopidogrel Hydrogen Sulfate Nazartinib Linsitinib Decitabine Lisaftoclax Fentanyl VX-407 Specific Nucleic Acid Sna-Her1 SODIUM IBANDRONATE Tenofovir Alafenamide Human Coagulation Factor Ix Buloxibutid Testosterone More therapies…

    Learn about Your Condition

    Adenomatous polyposis coli VEXAS syndrome Pleomorphic leiomyosarcoma Alagille syndrome Anorexia nervosa Renal disorder Lip and/or oral cavity cancer Psychotic disorder Foot deformity Meniere's disease Thermal burn Circulatory collapse Intestinal infarction Arterial disorder Depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Paclitaxel and Gemcitabine for Patients with Pancreatic Cancer Spread to the Abdomen

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel
    Italy

  • Study on High-Dose Vitamin D3 and Glycerol for Improving Wound Healing After Wisdom Tooth Removal in Patients with Vitamin D Insufficiency

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitamin D deficiency
    Investigated Drugs:
    • Glycerol
    • Colecalciferol
    Austria

  • Study of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Radiologically isolated syndrome
    Investigated Drugs:
    • Live Bcg Bacilli (Bacillus Calmette-Guerin), Brasilian Moreau Substrain
    • Sodium Chloride
    Italy

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Cefotaxime Sodium
    • Cefuroxime Sodium
    • Gentamicin
    Austria

  • Study of Datopotamab Deruxtecan for Patients with Triple-Negative Breast Cancer and New or Worsening Brain Metastases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    Austria Ireland

  • Study on the Use of FAPI-PET/CT and FDG-PET/CT Scans for Detecting Active Fibroblasts and Inflammation in Patients with Acute Phase Peyronie’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands
Previous Page
1 … 293 294 295 296 297 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!